| Carina Signori, DO, MPH | |
|
12 St Paul Dr Ste 210, Chambersburg, PA 17201-1035 | |
| (717) 217-6820 | |
| (717) 217-6942 |
| Full Name | Carina Signori |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 19 Years |
| Location | 12 St Paul Dr Ste 210, Chambersburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144435819 | NPI | - | NPPES |
| 102731384 0001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 5101016449 (Michigan) | Secondary |
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | OS016141 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Holy Spirit Hospital | Camp hill, PA | Hospital |
| Chambersburg Hospital | Chambersburg, PA | Hospital |
| Pinnacle Health Hospitals | Harrisburg, PA | Hospital |
| Milton S Hershey Medical Center | Hershey, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Penn State Health Community Medical Group Llc | 8729351077 | 646 |
News Archive
Ethicon, a medical device company of the Johnson & Johnson family of companies, today announced a definitive agreement to acquire NeuWave Medical, Inc., a privately held medical device company that manufactures and markets minimally invasive soft tissue microwave ablation systems.
Use of a computer environment is a new and fast-developing field in pediatric neurorehabilitation. The first longitudinal study in Estonia on the cognitive and social rehabilitation of children with acquired brain injury was completed at the University of Tartu, confirming the efficiency of using computer-based programs and virtual reality for improving children's attention, visuospatial abilities and social skills.
A Food and Drug Administration investigation last year found that Masimo Corp. did not adequately look into reports of problems with its devices, ProPublica reports, even though the company owner, Joe Kiani, has created a foundation dedicated to eliminating medical mistakes. In addition, the Boston Globe examines how medical technology companies are looking for new strategies to boost sales.
A study published in Briefings in Functional Genomics investigated how epigenetics can modulate human's genetic program - it can emphasize or silence genes.
Counting the amount of a type of normal cell circulating in the blood of people with cancer could predict whether a tumor progresses or responds to therapy, a new study led by the University of Michigan Comprehensive Cancer Center has found. The finding could give doctors an early indication of whether a treatment will be successful, sparing patients months of an ineffective therapy.
› Verified 2 days ago
| Entity Name | Spirit Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093013328 PECOS PAC ID: 8022922202 Enrollment ID: O20040402000053 |
News Archive
Ethicon, a medical device company of the Johnson & Johnson family of companies, today announced a definitive agreement to acquire NeuWave Medical, Inc., a privately held medical device company that manufactures and markets minimally invasive soft tissue microwave ablation systems.
Use of a computer environment is a new and fast-developing field in pediatric neurorehabilitation. The first longitudinal study in Estonia on the cognitive and social rehabilitation of children with acquired brain injury was completed at the University of Tartu, confirming the efficiency of using computer-based programs and virtual reality for improving children's attention, visuospatial abilities and social skills.
A Food and Drug Administration investigation last year found that Masimo Corp. did not adequately look into reports of problems with its devices, ProPublica reports, even though the company owner, Joe Kiani, has created a foundation dedicated to eliminating medical mistakes. In addition, the Boston Globe examines how medical technology companies are looking for new strategies to boost sales.
A study published in Briefings in Functional Genomics investigated how epigenetics can modulate human's genetic program - it can emphasize or silence genes.
Counting the amount of a type of normal cell circulating in the blood of people with cancer could predict whether a tumor progresses or responds to therapy, a new study led by the University of Michigan Comprehensive Cancer Center has found. The finding could give doctors an early indication of whether a treatment will be successful, sparing patients months of an ineffective therapy.
› Verified 2 days ago
| Entity Name | Penn State Health Community Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861988644 PECOS PAC ID: 8729351077 Enrollment ID: O20170907002279 |
News Archive
Ethicon, a medical device company of the Johnson & Johnson family of companies, today announced a definitive agreement to acquire NeuWave Medical, Inc., a privately held medical device company that manufactures and markets minimally invasive soft tissue microwave ablation systems.
Use of a computer environment is a new and fast-developing field in pediatric neurorehabilitation. The first longitudinal study in Estonia on the cognitive and social rehabilitation of children with acquired brain injury was completed at the University of Tartu, confirming the efficiency of using computer-based programs and virtual reality for improving children's attention, visuospatial abilities and social skills.
A Food and Drug Administration investigation last year found that Masimo Corp. did not adequately look into reports of problems with its devices, ProPublica reports, even though the company owner, Joe Kiani, has created a foundation dedicated to eliminating medical mistakes. In addition, the Boston Globe examines how medical technology companies are looking for new strategies to boost sales.
A study published in Briefings in Functional Genomics investigated how epigenetics can modulate human's genetic program - it can emphasize or silence genes.
Counting the amount of a type of normal cell circulating in the blood of people with cancer could predict whether a tumor progresses or responds to therapy, a new study led by the University of Michigan Comprehensive Cancer Center has found. The finding could give doctors an early indication of whether a treatment will be successful, sparing patients months of an ineffective therapy.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carina Signori, DO, MPH 785 5th Ave, Suite 3, Chambersburg, PA 17201-4232 Ph: (717) 263-9555 | Carina Signori, DO, MPH 12 St Paul Dr Ste 210, Chambersburg, PA 17201-1035 Ph: (717) 217-6820 |
News Archive
Ethicon, a medical device company of the Johnson & Johnson family of companies, today announced a definitive agreement to acquire NeuWave Medical, Inc., a privately held medical device company that manufactures and markets minimally invasive soft tissue microwave ablation systems.
Use of a computer environment is a new and fast-developing field in pediatric neurorehabilitation. The first longitudinal study in Estonia on the cognitive and social rehabilitation of children with acquired brain injury was completed at the University of Tartu, confirming the efficiency of using computer-based programs and virtual reality for improving children's attention, visuospatial abilities and social skills.
A Food and Drug Administration investigation last year found that Masimo Corp. did not adequately look into reports of problems with its devices, ProPublica reports, even though the company owner, Joe Kiani, has created a foundation dedicated to eliminating medical mistakes. In addition, the Boston Globe examines how medical technology companies are looking for new strategies to boost sales.
A study published in Briefings in Functional Genomics investigated how epigenetics can modulate human's genetic program - it can emphasize or silence genes.
Counting the amount of a type of normal cell circulating in the blood of people with cancer could predict whether a tumor progresses or responds to therapy, a new study led by the University of Michigan Comprehensive Cancer Center has found. The finding could give doctors an early indication of whether a treatment will be successful, sparing patients months of an ineffective therapy.
› Verified 2 days ago
Ryan R Gaffney, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 835 5th Ave, Chambersburg, PA 17201 Phone: 717-263-0629 Fax: 717-263-7105 | |
Saba Memon, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-217-4300 | |
Dr. Farshad Sepahpanah, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-217-4300 Fax: 717-217-4399 | |
Ryan M Decort, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2055 Scotland Ave, Chambersburg, PA 17201 Phone: 717-217-6055 Fax: 717-217-4329 | |
Gohar Arslan, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 22 St Paul Dr, Chambersburg, PA 17201 Phone: 717-217-6020 Fax: 717-217-6939 | |
Louis E Coda, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 112 N 7th St, Chambersburg, PA 17201 Phone: 717-262-4546 Fax: 717-263-1146 | |
Awais Ammar, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 20 Parkwood Dr Ste 2, Chambersburg, PA 17201 Phone: 717-263-7757 |